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Background: Melatonin has many roles, including bone remodeling and osseointegration of dental implants. The 
topical application of melatonin facilitated bone regeneration in bone defects. We evaluated the effects of topical 
application of melatonin on vertical bone augmentation in rat calvaria secluded spaces. 
Material and Methods: In total, 12 male Fischer rats were used and two plastic caps were fixed in the calvarium. 
One plastic cap was filled with melatonin powder and the other was left empty. 
Results: Newly generated bone at bone defects and within the plastic caps was evaluated using micro-CT and 
histological sections. New bone regeneration within the plastic cap was increased significantly in the melatonin 
versus the control group. 
Conclusions: Melatonin promoted vertical bone regeneration in rat calvaria in the secluded space within the plas-
tic cap.
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Guided bone regeneration (GBR) has been developed to 
regenerate bone at localized bone defects where there 
is insufficient bone volume for dental implant place-
ment. However, the quality and amount of regenerated 
bone is different from that needed with alveolar ridge 
deformities. Vertical bone augmentation (bone gener-
ated in a space in which bone had not existed before) 
is especially difficult to achieve (1). Previous animal 
studies have investigated vertical bone augmentation in 
secluded spaces using standardized devices such as tita-
nium or plastic caps (2-4). However, challenges remain 
in achieving efficient vertical bone augmentation.
Melatonin functions in various physiological processes 
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such as blood pressure regulation, immune function, 
and oral condition maintenance. Melatonin has many 
roles, including bone remodeling and osseointegration 
of dental implants, and it has been implicated in perio-
dontal disease and oral cancer (5). The role of melatonin 
in hard tissue has attracted attention. Melatonin may 
play an important role in bone healing processes due 
to its antioxidant properties, regulation of bone cells, 
and promotion of angiogenesis. Several studies have in-
vestigated its use to improve and accelerate bone heal-
ing in therapy (6,7). Recent studies showed that topical 
application of melatonin increased bone formation and/
or bone contact around dental implants (8,9) and facili-
tated bone regeneration in bone defects (10,11).
The purpose of this study was to investigate the effects 
of melatonin on vertical bone augmentation in secluded 
spaces created with plastic caps in rat calvaria.
Material and Methods
Animals
In total, 12 male Fischer rats (9 weeks old, 250-300 g) 
were used. The animals were kept in plastic cages in 
an experimental animal room (temperature 22°C, 55% 
humidity, 12/12-h light/dark cycle) with access to food 
and water ad libitum. This study was approved by the 
Animal Experimentation Committee of Nihon Univer-
sity School of Dentistry, Japan (AP12D009).
Experimental design
The animals were pre-medicated by inhalation of isoflu-
rane anesthetic and were subjected to general anesthesia 
by intraperitoneal injection of a mixture of 0.15 mg/kg 
dexmedetomidine hydrochloride, 2.0 mg/kg midazolam, 
and 2.5 mg/kg butorphanol tartrate. An intraperitoneal 
injection of 0.5 mL of a 1:80,000 dilution of lidocaine 
(Xylocaine; Astra Zeneca, Osaka, Japan) was admin-
istered to control bleeding and provide additional an-
esthesia. In each rat, a circular groove was made on each 
side of the midsuture using a trephine burr with an inner 
diameter of 5 mm under profuse irrigation with sterile 
saline. Five small holes were drilled using a number 2 
round burr to induce bleeding (Fig. 1a). A cylindrical 
plastic cap (standardized column shape measuring 1.5 
mm in height and 4.4 mm in diameter) was placed on 
both sides of the circular grooves, and composite resin 
landmarks were fixed onto the top of the plastic caps. 
One cap was filled with melatonin powder (10 mg, mela-
tonin group) and the other cap remained empty (control 
group). The caps were fixed in place with light-cured 
4-META resin (Fig. 1b).
Micro CT analysis
Images were reconstructed on a personal computer us-
ing the i-View software (Kitasenjyu Radist Dental Clin-
ic, i-View Image Center, Tokyo, Japan). The relative CT 
values of cortical bone and soft tissue were measured 
by micro-CT (R-mCT2 system; Rigaku, Tokyo, Japan). 
The bone volume (BV) within the plastic caps from 
voxel images was examined using BV-measurement 
software (Kitasenjyu Radist Dental Clinic). Using the 
BV measurement software, the gray values and num-
bers of voxels with the corresponding gray values were 
calculated in regions of interest (ROIs). The BV was 
measured on the first postoperative day in the ROIs and 
again twice per week under the same conditions. Then, 
the enhanced BV was calculated by subtracting the BV 
on day 1 from each of the subsequent values.
Histological and histomorphometric analyses
The rats were sacrificed with excess CO2 gas inhalation 
at 8 and 12 weeks (i.e., after the last micro-CT scan). 
The calvarial bone with bone defects or with the fixed 
plastic cap was resected, fixed in 10% neutral-buffered 
formalin, dehydrated, embedded in paraffin wax, and 
processed into 5-µm sections for hematoxylin and eosin 
Fig. 1. (a) A circular groove was made using a trephine burr and five small holes were drilled using a round burr for marrow pen-
etration. (b) One side of the plastic cap was filled with melatonin powder 10 mg (melatonin) and the other side remained empty 
(control). A plastic cap was fixed to each groove.
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staining. One sagittal decalcified ground section from 
the center of the bone defect and a plastic cap were 
prepared using a microtome. Histological and morpho-
metric assessments of the sections were made under a 
light microscope. The percentage total area and height 
of newly generated tissue within each space was cal-
culated for each central cross-sectional histological 
section. The mean numbers of osteoblast-like cells and 
blood vessels were counted in newly generated bone. 
Images of the histological sections were evaluated by an 
examiner blinded to the groups.
Statistical analysis
Means and standard deviations were calculated for 
BV, defect closure rate, percentages of areas of newly 
generated bone and bone height. The Wilcoxon signed-
rank test was used to analyze differences between the 
melatonin and control groups. In all analyses, P values 
< 0.05 were taken to indicate statistical significance.
Results
CT images
Analysis of the micro-CT images indicated that the ra-
diopacity contrast increased gradually, in a time-depend-
ent manner, in both the experimental and control groups. 
The thin layer of radiopacity transferred almost to the top 
of the plastic cap at 12 weeks in the melatonin groups. On 
the other hand, a thin layer of radiopacity only reached 
one-third of the cap at 12 weeks in the control groups 
(Fig. 2). BV was enhanced significantly at 4, 6, 8, 10, and 
12 weeks, compared with the control (Table 1).
Histological and histomorphometric analyses
New bone regeneration reached the top of the plastic 
cap in the melatonin group; however, it reached to about 
one-third of the plastic cap in the control group. Some 
blood vessels were observed in the newly generated 
bone in the melatonin groups (Fig. 3).
The total percentages of areas of new bone under the 
Fig. 2. Micro-CT image of the plastic cap in the melatonin group and control group at 0 and 12 weeks. The thin layer of radiopac-
ity gradually increased both groups. The melatonin groups’ increased radopacity was evident compared to the control groups.
Table 1. Bone volumes in the melatonin and control groups 
at 2, 4, 6, 8, 10, and 12 weeks. Significant differences were 
observed at 4 to 12 weeks. (P < 0.05).
Weeks Melatonin group Control group  
（mm3） 
2      1.37 ± 0.3 1.18 ± 0.2 
4 8.34 ± 3.5* 4.28 ± 1.5 
6 10.69 ± 3.3* 5.31 ± 1.9 
8 11.67 ± 3.4* 6.21 ± 2.3 
10 12.60 ± 3.3* 7.12 ± 2.4 
12 13.40 ± 3.0* 8.22 ± 2.8 
 N = 12* Wilcoxon signed-rank test, P<0.05
plastic cap were significantly different between the me-
latonin and control groups at 12 weeks. The height of 
newly generated bone was significantly greater in the me-
latonin group (Table 2). Significantly larger numbers of 
micro vessels and osteoblast-like cells were observed in 
the control group than in the melatonin group (Table 3).
Discussion
The present study showed that melatonin increased 
vertical bone augmentation in a secluded space created 
with a plastic cap. 
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The secluded space created by the plastic cap was in-
tended as a model for vertical bone augmentation, as in 
dental implant placement. The results showed that the 
height of newly generated bone was significantly great-
er in the melatonin group, and the generated bone was 
well mineralized. Our previous studies found that some 
scaffolds or growth factors were needed for newly gen-
erated bone to reach the top of the plastic cap (2,3,11). 
Prior to implanting, the topical application of melatonin 
powder and growth hormone (GH) at osteotomy sig-
nificantly enhanced new bone formation around tita-
nium implants in the early stage of healing (12). This 
suggested that melatonin functioned as a growth factor 
to enhance new bone formation. Furthermore, local ap-
plication of melatonin to dental implants increased the 
bone implant contact (BIC) area and inter-thread bone 
at 4-12 weeks (12-14). Melatonin acted on the bone as 
a local growth factor with paracrine effects on nearby 
cells (12,13). Enhancing BIC signifies a direct action of 
melatonin on osteoblasts, inducing a higher rate of mat-
uration of preosteoblasts to osteoblasts, in terms of both 
quantity and speed, with a higher rate of production of 
the osseous matrix and its subsequent calcification. 
The present study found significantly larger numbers 
of osteoblast-like cells in melatonin groups compared 
to control groups. In vitro studies have demonstrated 
that melatonin promotes osteoblast proliferation (15,16). 
Furthermore, melatonin and GH function through sev-
eral related mechanisms; however, each also plays other 
roles. Melatonin is more important in osteoblast differ-
entiation and osteoclast inhibition (13). A recent study 
showed that melatonin promoted osteoblastic differenti-
ation and mineralization of mouse preosteoblastic cells 
under hypoxic conditions (17). Bone healing and regen-
eration are both hampered under hypoxic conditions.
Fig. 3. Histological observation of the plastic cap at 12 weeks in the melatonin and control groups. a) Melatonin groups. b) Con-
trol groups. c) Higher magnification of inflamed area in melatonin group (×10). Arrow heads indicate micro vessels. d) Higher 




Height of newly 
generated bone 
Melatonin group   63.4±6.1* 63.8±7.3* 
Control group   29.6±3.3 25.6±2.8 
  
Table 2. The total percentages of newly generate bone and height under the plastic cap. 
N = 12* Wilcoxon signed-rank test, P<0.05
 Osteoblast-like 
cells Blood vessels 
Melatonin group   423.3±69.7* 54.8±3.2* 
Control group 256.3±29.6 32.2±2.5 
 
Table 3. The numbers of micro vessels and osteoblast-like cells. 
N = 12* Wilcoxon signed-rank test, P < 0.05.
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We also demonstrated that the number of blood vessels 
increased significantly in the melatonin group versus the 
control group. Melatonin enhanced angiogenesis during 
the repair of bone defects in rabbit tibia (11). Melatonin 
maintained capillary homeostasis because the wound tis-
sue includes many blood vessels. Another study showed 
that melatonin administration had positive effects on both 
angiogenesis and wound healing (18). Angiogenesis plays 
a key role in bone regeneration. Previous studies showed 
that angiogenesis preceded bone regeneration in calvaria 
bone defects and secluded spaces (19,20). The local ap-
plication of melatonin significantly induced angiogenesis 
during the first 4 weeks (11). Another study reported that 
the local application of melatonin resulted in a rapid in-
crease in bone formation at 2 weeks (10).
Other studies revealed that local application of mela-
tonin enhanced bone regeneration in concave defects. 
Ramilez-Fernandez et al. (11) generated 5-mm-diameter 
concave defects and implanted 1.2 mg melatonin pow-
der in tibiae. Calvo-Guirade et al. (21) created concave 
defects ~4 mm in diameter using a surgical drill in the 
tibia and implanted 5 mg of melatonin impregnated in a 
resorbable sponge. In the present study, only melatonin 
powder was placed in the cap (10 mg). No melatonin 
remained in the regenerated bone, and the tissue was 
well mineralized. However, melatonin powder is diffi-
cult to use in GBR because the powder does not tend to 
hold its form. Clafshenkel et al. (22) implanted calcium 
aluminate discs attached to melatonin in calvarial bone 
defects in rats. They indicated that the calcium–mela-
tonin scaffolds had the potential to provide a moldable, 
bioactive scaffold that would target bone-regenerating 
activity directly to sites of bone loss. Thus, melatonin 
can be used with other scaffolds to extend clinical ap-
plications such as GBR in implant placement.
In conclusion, melatonin promoted vertical bone regen-
eration in a secluded space using a plastic cap. Further 
studies are needed to fully evaluate the benefit of mela-
tonin in enhancing bone regeneration.
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